Faricimab for High-frequent Aflibercept Treated Neovascular Age-related Macular Degeneration
Clinical trial NCT05941715 · COMPLETED
Trial details
- NCT number
- NCT05941715
- Sponsor
- Medical University of Graz
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-04
- Primary completion
- 2024-09-25
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.